tiprankstipranks

Vigil Neuroscience sees cash runway into 2026

Vigil Neuroscience sees cash runway into 2026

Cash, cash equivalents, and marketable securities were $97.8 million as of December 31, 2024, compared to $111.3 million as of September 30, 2024. The Company expects its cash, cash equivalents and marketable securities will fund its operational plans into 2026.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue